Please assess the completion status of the following clinical trial:

Trial Title: Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1) : Multi-centre, Prospective, Randomized Controlled Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Confirmed novel influenza A(H1N1) case with laboratory evidence~* 70 years ≥ age ≥ 14years~* Within 72hr after the onset of symptoms(body temperature≥37.5℃ with at least one respiratory symptom (cough, sore throat, or nasal symptom)~Exclusion Criteria:~* Age \< 14 years or \> 70 years~* Bronchitis, pneumonia, pleural fluid and interstitial infiltration showed by Chest radiology(x-ray or CT)~* Severe chronic underlying diseases: severe COPD(FEV1/EVC \<70% and FEV1 \<30% predicted or respiratory failure or congestive heart failure), severe hepatic disfunction（ALT or AST ≥3 times normal elevation), renal disfunction（Cr\>2mg/dL), chronic heart failure(NYHA Ⅲ-Ⅳ grade）~* Immunocompromised patients(cancer, organ transplant, AIDS and a history of treatment with immunosuppressive drug and glucocorticoids in the past 3 months)~* Taken Chinese medicinal herbs, antiviral or antibiotic drug in the past 2 weeks~* Inoculation influenza vaccination~* One of the following items appeared at the enrollment~  * respiratory failure：PaO2\<60mmHg and/or PCO2\>50mmHg or PaO2/FiO2≤300~ * circulation failure: despite adequate fluid resuscitation and cardiac output, systolic \<90mmHg or requirement inotropic support~ * renal function failure: despite adequate fluid resuscitation and cardiac output, urine ≤ 0.5ml/kg.h, Cr or BUN≥1 time normal elevation~ * hepatic function failure: total bilirubin\>34μmol/L or ALT/AST ≥3 times normal - Other unappropriated enrollment situations considered by investigator

- Gender: ALL
- Minimum Age: 14 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- blank (Type: EXPERIMENTAL): do not take antiviral therapy
- Oseltamivir (Type: EXPERIMENTAL): antiviral therapy
- chinese medicinary herbs (Type: EXPERIMENTAL): antiviral therapy
- oseltalmivir and chinese medicinal herbs (Type: EXPERIMENTAL): combination antiviral therapy

Based on this trial design, predict the completion outcome and termination type (if applicable).